Jonathan Lewis News
-
The smart money shows no sign of losing confidence in the Australian dollar as analysts belatedly acknowledge the appeal of a high-yielding currency with a world- beating developed economy.
-
Ziopharm Oncology Inc., a maker of experimental cancer treatments, tumbled the most in seven years in New York trading after saying it would end plans to develop its lead drug candidate for soft tissue tumors.
-
Ziopharm Oncology Inc., a developer of experimental cancer drugs, is in talks with potential partners to market its lead compound, palifosfamide, Chief Executive Officer Jonathan Lewis said.
-
Central-bank reserve shifts indicate the best foreign-exchange returns may be found by avoiding the “fading four” most-traded currencies in favor of the next tier, according to Samson Capital Advisors LLC.
-
In the battle of Zela, Julius Caesar came, saw, and conquered. At the English National Opera, he suffers a rather different fate.
-
Nomura Holdings Inc. trailed the world’s biggest investment banks last quarter in generating shareholder returns, underscoring the challenge for Chief Executive Officer Koji Nagai in trimming costs without sacrificing revenue.
-
At a time when nations from Japan to Brazil are struggling to keep currency gains from damaging their economies, Reserve Bank of Australia Governor Glenn Stevens is welcoming a stronger exchange rate.
-
Jonathan L. Auerbach, who explored new frontiers for investors as co-founder of Auerbach Grayson & Co., a brokerage that specializes in international trading, has died. He was 70.
-
Tax-exempt bonds are yielding more than Treasuries for the first time since the financial crisis, a relationship that history shows doesn’t last, especially as the Federal Reserve kindles inflation expectations.
-
An experimental drug from Ziopharm Oncology Inc. helped keep fast-growing sarcomas, lethal tumors that can grow to the size of basketballs, in check 77% longer than a standard treatment, a company-sponsored study found.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page